CME

Nephrology and Urology CME/CE Courses

myCMEYour search for high-quality, complimentary CME/CE stops right here. The courses below are presented by myCME, the continuing education engine in Haymarket Medical Network’s (HMN) expanding portfolio of clinical websites. Below you’ll find practice-relevant courses that carry valuable CME/CE credit. Simply click any link to get started earning credit on myCME.

Featured Courses

Virtual Symposium - Addressing the Impacts of Iron Deficiency in HF: Advances in Diagnosis and Management

Virtual Symposium – Addressing the Impacts of Iron Deficiency in HF: Advances in Diagnosis and Management | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists
In this symposium, experts will discuss data from recent and ongoing trials of iron repletion in patients with HF to highlight the importance of diagnosis and proper management of this common comorbidity and review recent updates to established HF treatment guidelines that emphasize ID recognition and treatment. Additionally, the program will educate clinicians on the differences in oral versus intravenous iron formulations.
Critical Impact of Inflammation in Lysosomal Diseases: Unlocking Future Treatments and Improving Outcomes

Critical Impact of Inflammation in Lysosomal Diseases: Unlocking Future Treatments and Improving Outcomes | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s)
The goal of this activity, which was held at WORLDSymposium 2021 will be to address the critical role of inflammation in lysosomal diseases, with a specific focus on inflammation in Gaucher disease, mucopolysaccharidosis type II (MPS II), and metachromatic leukodystrophy (MLD). Gaucher disease, MPS II, and MLD are three lysosomal diseases in which inflammation plays a significant role in disease progression and associated neurodegeneration.
100 Years of Innovation in Insulin Therapy

100 Years of Innovation in Insulin Therapy

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
This program is designed to review key advances in insulin therapy from its introduction in the early 1920s to current innovations.
Critical Role of APPs in the Success of Minimally Invasive Approaches for BPH

Critical Role of APPs in the Success of Minimally Invasive Approaches for BPH

ANCC Contact Hour(s), AAPA Category I CME credit
An increase in the aging population in the United States in the next few years is expected to create high demand for BPH treatments. Prostatic urethral lift, an AUA recommended noninvasive approach, may be an alternative option for patients with lower urinary tract symptoms and provides another tool in the armamentarium for treating BPH.
Virtual Symposium: The Challenge of Chronic Hyperkalemia in Cardiometabolic Patients: Advances and Opportunities

The Challenge of Chronic Hyperkalemia in Cardiometabolic Patients | myCME

AMA PRA Category 1 Credit(s)TM, CNE Contact Hour(s), CE for Pharmacists, CPEU Credit, ABIM MOC Points
This symposium will provide clinicians with clinical evidence on the new potassium-binding agents for the long-term management of hyperkalemia to improve guideline adherence and help clinicians move toward optimizing guideline-directed medical therapy for hyperkalemic patients with HF and CKD.
Expert Perspectives on Rare Disease: Promoting Recognition, Diagnosis and Treatment of Cold Agglutinin Disease

Promoting Recognition, Diagnosis and Treatment of CAD

AMA PRA Category 1 Credit(s)TM, ANCC Contact Hour(s)
In this activity, Catherine M. Broome, MD, and Alexander Röth, MD, provide an understanding of the pathogenesis of Cold Agglutinin Disease (CAD) caused by cold-reacting IgM autoantibodies and reveal common clinical features.
Examining the Clinical Potential of PARP Inhibitors in Prostate Cancer

Examining the Clinical Potential of PARP Inhibitors in Prostate Cancer

AMA PRA Category 1 Credit(s)TM
The advent of poly-(ADP ribose)-polymerase (PARP) inhibitors for a variety of malignancies has led to the evaluation of their use in patients with metastatic castrate resistant prostate cancer (mCRPC), and has the potential to shift treatment paradigms for these patients.
Disease States and Staging of Castration-Sensitive Prostate Cancer

Disease States and Staging of Castration-Sensitive Prostate Cancer

AMA PRA Category 1 Credit(s)TM, CE for Pharmacists
The first episode of this CME Outfitters podcast series on castration-sensitive prostate cancer (CSPC) will outline the current state of staging in CSPC and clarify the findings of reports detailing the pathology of prostate cancer specimens.

Click for More Renal and Urology Courses

Next post in CME Articles